S. Brown

Designing phase II trials in cancer: a systematic review and guidance

M. Buyse, W. Gregory, J. Brown, 2011, British Journal of Cancer.

Closeness to death and quality of life in advanced lung cancer patients.

H. Thorpe, V. Napp, J. Brown, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis

L. Coates, A. Moverley, P. Emery, 2013, BMC Musculoskeletal Disorders.

Adhesions and incisional hernias following laparoscopic versus open surgery for colorectal cancer in the CLASICC trial

D. Jayne, M. Parker, P. Guillou, 2009, The British journal of surgery.

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

T. Powles, P. Nathan, N. Vasudev, 2019, BMC Cancer.

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results

R. Eastell, C. Twelves, I. Macpherson, 2022, Journal of bone oncology.

Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study

M. Dowsett, T. Perren, J. Sainsbury, 2007, British Journal of Cancer.

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study

G. Morgan, W. Gregory, F. Davies, 2019, The Lancet. Haematology.